244 related articles for article (PubMed ID: 10564166)
1. Epoxide hydrolases regulate epoxyeicosatrienoic acid incorporation into coronary endothelial phospholipids.
Weintraub NL; Fang X; Kaduce TL; VanRollins M; Chatterjee P; Spector AA
Am J Physiol; 1999 Nov; 277(5):H2098-108. PubMed ID: 10564166
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of endothelium-dependent relaxation by epoxyeicosatrienoic acids.
Weintraub NL; Fang X; Kaduce TL; VanRollins M; Chatterjee P; Spector AA
Circ Res; 1997 Aug; 81(2):258-67. PubMed ID: 9242187
[TBL] [Abstract][Full Text] [Related]
3. 14,15-Dihydroxyeicosatrienoic acid relaxes bovine coronary arteries by activation of K(Ca) channels.
Campbell WB; Deeter C; Gauthier KM; Ingraham RH; Falck JR; Li PL
Am J Physiol Heart Circ Physiol; 2002 May; 282(5):H1656-64. PubMed ID: 11959628
[TBL] [Abstract][Full Text] [Related]
4. Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation.
Oltman CL; Weintraub NL; VanRollins M; Dellsperger KC
Circ Res; 1998 Nov; 83(9):932-9. PubMed ID: 9797342
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 metabolites of arachidonic acid: rapid incorporation and hydration of 14,15-epoxyeicosatrienoic acid in arterial smooth muscle cells.
Fang X; Kaduce TL; Weintraub NL; Spector AA
Prostaglandins Leukot Essent Fatty Acids; 1997 Oct; 57(4-5):367-71. PubMed ID: 9430380
[TBL] [Abstract][Full Text] [Related]
6. Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells. Implications for the vascular effects of soluble epoxide hydrolase inhibition.
Fang X; Kaduce TL; Weintraub NL; Harmon S; Teesch LM; Morisseau C; Thompson DA; Hammock BD; Spector AA
J Biol Chem; 2001 May; 276(18):14867-74. PubMed ID: 11278979
[TBL] [Abstract][Full Text] [Related]
7. Effect of soluble epoxide hydrolase inhibition on epoxyeicosatrienoic acid metabolism in human blood vessels.
Fang X; Weintraub NL; McCaw RB; Hu S; Harmon SD; Rice JB; Hammock BD; Spector AA
Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2412-20. PubMed ID: 15284062
[TBL] [Abstract][Full Text] [Related]
8. 14,15-epoxyeicosatrienoic acid represents a transferable endothelium-dependent relaxing factor in bovine coronary arteries.
Gauthier KM; Edwards EM; Falck JR; Reddy DS; Campbell WB
Hypertension; 2005 Apr; 45(4):666-71. PubMed ID: 15699460
[TBL] [Abstract][Full Text] [Related]
9. Human coronary endothelial cells convert 14,15-EET to a biologically active chain-shortened epoxide.
Fang X; Weintraub NL; Oltman CL; Stoll LL; Kaduce TL; Harmon S; Dellsperger KC; Morisseau C; Hammock BD; Spector AA
Am J Physiol Heart Circ Physiol; 2002 Dec; 283(6):H2306-14. PubMed ID: 12388281
[TBL] [Abstract][Full Text] [Related]
10. Epoxyeicosatrienoic acid metabolism in arterial smooth muscle cells.
Fang X; VanRollins M; Kaduce TL; Spector AA
J Lipid Res; 1995 Jun; 36(6):1236-46. PubMed ID: 7666001
[TBL] [Abstract][Full Text] [Related]
11. 14,15-Epoxyeicosatrienoic acid metabolism in endothelial cells.
VanRollins M; Kaduce TL; Knapp HR; Spector AA
J Lipid Res; 1993 Nov; 34(11):1931-42. PubMed ID: 8263417
[TBL] [Abstract][Full Text] [Related]
12. 14,15-Epoxyeicosa-5(Z)-enoic acid: a selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteries.
Gauthier KM; Deeter C; Krishna UM; Reddy YK; Bondlela M; Falck JR; Campbell WB
Circ Res; 2002 May; 90(9):1028-36. PubMed ID: 12016270
[TBL] [Abstract][Full Text] [Related]
13. Increases in levels of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids (EETs and DHETs) in liver and heart in vivo by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and in hepatic EET:DHET ratios by cotreatment with TCDD and the soluble epoxide hydrolase inhibitor AUDA.
Diani-Moore S; Ma Y; Gross SS; Rifkind AB
Drug Metab Dispos; 2014 Feb; 42(2):294-300. PubMed ID: 24311719
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of arachidonic acid to epoxyeicosatrienoic acids, hydroxyeicosatetraenoic acids, and prostaglandins in cultured rat hippocampal astrocytes.
Amruthesh SC; Boerschel MF; McKinney JS; Willoughby KA; Ellis EF
J Neurochem; 1993 Jul; 61(1):150-9. PubMed ID: 8515261
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of Ca2+ signaling in endothelial cells by 11,12-epoxyeicosatrienoic acid.
Mombouli JV; Holzmann S; Kostner GM; Graier WF
J Cardiovasc Pharmacol; 1999 May; 33(5):779-84. PubMed ID: 10226866
[TBL] [Abstract][Full Text] [Related]
16. Endothelium-dependent relaxation and hyperpolarization in guinea-pig coronary artery: role of epoxyeicosatrienoic acid.
Eckman DM; Hopkins N; McBride C; Keef KD
Br J Pharmacol; 1998 May; 124(1):181-9. PubMed ID: 9630358
[TBL] [Abstract][Full Text] [Related]
17. Effect of protein kinase C modulators on 14,15-epoxyeicosatrienoic acid incorporation into astroglial phospholipids.
Shivachar AC; Willoughby KA; Ellis EF
J Neurochem; 1995 Jul; 65(1):338-46. PubMed ID: 7790878
[TBL] [Abstract][Full Text] [Related]
18. Differences in positional esterification of 14,15-epoxyeicosatrienoic acid in phosphatidylcholine of porcine coronary artery endothelial and smooth muscle cells.
Fang X; Weintraub NL; Spector AA
Prostaglandins Other Lipid Mediat; 2003 Apr; 71(1-2):33-42. PubMed ID: 12749592
[TBL] [Abstract][Full Text] [Related]
19. Functional implications of a newly characterized pathway of 11,12-epoxyeicosatrienoic acid metabolism in arterial smooth muscle.
Fang X; Kaduce TL; Weintraub NL; VanRollins M; Spector AA
Circ Res; 1996 Oct; 79(4):784-93. PubMed ID: 8831502
[TBL] [Abstract][Full Text] [Related]
20. Endothelium-derived 2-arachidonylglycerol: an intermediate in vasodilatory eicosanoid release in bovine coronary arteries.
Gauthier KM; Baewer DV; Hittner S; Hillard CJ; Nithipatikom K; Reddy DS; Falck JR; Campbell WB
Am J Physiol Heart Circ Physiol; 2005 Mar; 288(3):H1344-51. PubMed ID: 15528233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
